BENEFIT PLANS (Details) (USD $) | 0 Months Ended | 1 Months Ended | 3 Months Ended | 9 Months Ended | 0 Months Ended | |
Dec. 01, 2014 | Jul. 01, 2014 | Apr. 07, 2014 | Dec. 31, 2013 | Nov. 30, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Nov. 17, 2014 | Aug. 31, 2009 |
employee |
Number of Options | | | | | | | | | | | |
Outstanding, beginning balance (in shares) | | | | | | | | 4,458,000 | | | |
Granted (shares) | 120,000 | 750,000 | 140,000 | | 685,000 | | | 1,695,000 | | | |
Exercised (shares) | | | | | | | | -1,378,000 | | | |
Forfeited/Cancelled | | | | | | | | -194,000 | | | |
Outstanding, beginning balance (in shares) | | | | | | 4,581,000 | | 4,581,000 | | | |
Number of Options vested and expected to vest, net of estimated forfeitures (in shares) | | | | | | 4,351,000 | | 4,351,000 | | | |
Number of Options exercisable (in shares) | | | | | | 454,000 | | 454,000 | | | |
Weighted Average Exercise Price | | | | | | | | | | | |
Outstanding, beginning balance (in dollars per share) | | | | | | | | $3.48 | | | |
Granted (in dollars per share) | $1.08 | $2.25 | $3.58 | | $1.30 | | | $4.04 | | | |
Exercised (in dollars per share) | | | | | | | | $1.85 | | | |
Forfeited/Canceled (in dollars per share) | | | | | | | | $7.30 | | | |
Outstanding, ending balance (in dollars per share) | | | | | | $4.01 | | $4.01 | | | |
Options vested and expected to vest, net of estimated forfeitures, Weighted Average Exercise Price (in dollars per share) | | | | | | $3.98 | | $3.98 | | | |
Options exercisable, Weighted Average Exercise Price (in dollars per share) | | | | | | $6.76 | | $6.76 | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Outstanding options, Weighted Average Remaining Contractual Term in Years | | | | | | | | 5 years 10 months 2 days | | | |
Outstanding vested and expected to vest, net of estimated forfeitures, Weighted Average Remaining Contractual Term in Years | | | | | | | | 5 years 7 months 21 days | | | |
Options exercisable, Weighted Average Remaining Contractual Term in Years | | | | | | | | 8 years 2 months 9 days | | | |
Options outstanding, Aggregate Intrinsic Value | | | | | | $1,680,000 | | $1,680,000 | | | |
Options vested and expected to vest, net of estimated forfeitures, Aggregate Intrinsic Value | | | | | | 1,670,000 | | 1,670,000 | | | |
Options exercisable, Aggregate Intrinsic Value | | | | | | 0 | | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Common shares reserved for issuance (in shares) | | | | 7,500,000 | | | 7,500,000 | | 7,500,000 | | 4,500,000 |
Increase in common shares reserved for issuance (in shares) | | | | 3,000,000 | | | | | | | |
Share-based compensation expense | | | | | | 1,699,000 | 3,907,000 | 5,571,000 | 14,413,000 | | |
Unrecognized compensation cost, weighted-average period | | | | | | | | 2 years 7 months 6 days | | | |
Unrecognized compensation cost | | | | | | | | | | | |
Total | | | | | | 6,100,000 | | 6,100,000 | | | |
2009 Covisint LTIP | | | | | | | | | | | |
Number of Options | | | | | | | | | | | |
Exercised (shares) | | | | | | | | -1,378,200 | | | |
Outstanding, beginning balance (in shares) | | | | | | 4,600,000 | | 4,600,000 | | | |
Unrecognized compensation cost | | | | | | | | | | | |
Total | | | | | | 6,128,000 | | 6,128,000 | | | |
2015 | | | | | | 846,000 | | 846,000 | | | |
2016 | | | | | | 2,757,000 | | 2,757,000 | | | |
2017 | | | | | | 1,674,000 | | 1,674,000 | | | |
2018 | | | | | | 851,000 | | 851,000 | | | |
Cost of revenue | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | -1,000 | 137,000 | 583,000 | 735,000 | | |
Research and development | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | 55,000 | 158,000 | 149,000 | 656,000 | | |
Selling and marketing | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | 424,000 | 1,117,000 | 1,369,000 | 5,153,000 | | |
Administrative and general | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | 1,221,000 | 2,495,000 | 3,470,000 | 7,869,000 | | |
Stock options | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Expiration period | | | | | | | | 10 years | | | |
Stock options | Vesting schedule one, fifth anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 25.00% | | | |
Stock options | Vesting schedule three, second anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 30.00% | | | |
Restricted Stock Units (RSUs) | | | | | | | | | | | |
Shares | | | | | | | | | | | |
Granted (in shares) | | 182,193 | | | | | | | | 155,795 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Granted, Weighted Average Grant-Date Fair Value (in dollars per share) | | $4.86 | | | | | | | | $2.79 | |
Number of employees granted options | | | | | | | | | | 5 | |
Restricted Stock Units (RSUs) | 2009 Covisint LTIP | | | | | | | | | | | |
Shares | | | | | | | | | | | |
Non-vested RSU outstanding, ending balance (in shares) | | | | | | 300,000 | | 300,000 | | | |
Restricted Stock Units (RSUs) | First anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 33.30% | | | |
Restricted Stock Units (RSUs) | Second anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 33.30% | | | |
Restricted Stock Units (RSUs) | Third anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 33.30% | | | |
Restricted Stock Units (RSUs) | Prior to First Anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | | | 100.00% | |
Performance-based Stock Awards | | | | | | | | | | | |
Shares | | | | | | | | | | | |
Non-vested RSU outstanding, ending balance (in shares) | | | | | | 681,000 | | 681,000 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation reversed due to cancellations | | | | | | | -2,900,000 | | | | |
Performance-based Stock Awards | 2009 Covisint LTIP | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | 1,700,000 | | 5,600,000 | | | |
Performance-based Stock Awards | Administrative and general | | | | | | | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Share-based compensation expense | | | | | | | -2,800,000 | | -2,500,000 | | |
Compuware | | | | | | | | | | | |
Number of Options | | | | | | | | | | | |
Outstanding, beginning balance (in shares) | | | | | | | | 472,000 | | | |
Granted (shares) | | | | | | | | 0 | | | |
Exercised (shares) | | | | | | | | -301,000 | | | |
Forfeited/Cancelled | | | | | | | | -171,000 | | | |
Outstanding, beginning balance (in shares) | | | | | | 0 | | 0 | | | |
Number of Options vested and expected to vest, net of estimated forfeitures (in shares) | | | | | | 0 | | 0 | | | |
Number of Options exercisable (in shares) | | | | | | 0 | | 0 | | | |
Weighted Average Exercise Price | | | | | | | | | | | |
Outstanding, beginning balance (in dollars per share) | | | | | | | | $9.23 | | | |
Exercised (in dollars per share) | | | | | | | | $8.28 | | | |
Forfeited/Canceled (in dollars per share) | | | | | | | | | | | |
Outstanding, ending balance (in dollars per share) | | | | | | $0 | | $0 | | | |
Options vested and expected to vest, net of estimated forfeitures, Weighted Average Exercise Price (in dollars per share) | | | | | | $0 | | $0 | | | |
Options exercisable, Weighted Average Exercise Price (in dollars per share) | | | | | | $0 | | $0 | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Outstanding options, Weighted Average Remaining Contractual Term in Years | | | | | | | | 0 years | | | |
Outstanding vested and expected to vest, net of estimated forfeitures, Weighted Average Remaining Contractual Term in Years | | | | | | | | 0 years | | | |
Options exercisable, Weighted Average Remaining Contractual Term in Years | | | | | | | | 0 years | | | |
Exercised, Aggregate Intrinsic Value | | | | | | | | 627,000 | | | |
Options outstanding, Aggregate Intrinsic Value | | | | | | | | | | | |
Options vested and expected to vest, net of estimated forfeitures, Aggregate Intrinsic Value | | | | | | | | | | | |
Options exercisable, Aggregate Intrinsic Value | | | | | | | | | | | |
Compuware | Stock options | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Expiration period | | | | | | | | 10 years | | | |
Compuware | Stock options | Vesting schedule one, third anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 50.00% | | | |
Compuware | Stock options | Vesting schedule one, fourth anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 25.00% | | | |
Compuware | Stock options | Vesting schedule two | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 25.00% | | | |
Award vesting period | | | | | | | | 4 years | | | |
Compuware | Stock options | Vesting schedule three, first anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 30.00% | | | |
Compuware | Stock options | Vesting schedule three, third anniversary | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 40.00% | | | |
Compuware | Restricted Stock Units (RSUs) | | | | | | | | | | | |
Additional Disclosures [Abstract] | | | | | | | | | | | |
Award vesting rights, percentage | | | | | | | | 25.00% | | | |
Award vesting period | | | | | | | | 4 years | | | |
Shares | | | | | | | | | | | |
Non-vested RSU outstanding, beginning balance (in shares) | | | | | | | | 182,000 | | | |
Granted (in shares) | | | | | | | | 0 | | | |
Released (in shares) | | | | | | | | -156,000 | | | |
Forfeited (in shares) | | | | | | | | -26,000 | | | |
Dividend equivalents, net (in shares) | | | | | | | | 0 | | | |
Non-vested RSU outstanding, ending balance (in shares) | | | | | | 0 | | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | | | | | | | | | |
Granted, Weighted Average Grant-Date Fair Value (in dollars per share) | | | | | | | | | | | |
Dividend equivalents, net, Weighted Average Grant-Date Fair Value (in dollars per share) | | | | | | | | $0 | | | |
Released, Aggregate Intrinsic Value | | | | | | | | $1,514,000 | | | |